Intervertebral DXM Gel Injection in Adults With Painful Lumbar Degenerative Disc Disease

NAUnknownINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 15, 2020

Primary Completion Date

October 31, 2021

Study Completion Date

October 31, 2021

Conditions
Degenerative Disc DiseaseChronic Lower Back PainDiscogenic PainIntervertebral Disc DegenerationLumbar Disc DiseaseLumbar Disc DegenerationLumbar Disc Pain
Interventions
DEVICE

Double Crosslink Microgel

"DXM hydrogel is a pH responsive Double Cross-Linked microgel based on single internally cross-linked microspheres (comprising a methacrylic acid-methyl methacrylate-ethylene glycol dimethacrylate copolymer)~The DXM gel is injected into the intervertebral disc (IVD) space via a standardised procedure similar to the routinely-performed Discography procedure. The disc approach described in the discography procedure has been reported to allow the injection of a solution in the centre of the disc. The injection of the gel takes about 2 min."

Trial Locations (1)

33300

RECRUITING

Polyclinique Bordeaux Nord Aquitaine Centre Vertebra, Bordeaux

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Excelya

INDUSTRY

lead

Gelmetix

INDUSTRY

NCT04727385 - Intervertebral DXM Gel Injection in Adults With Painful Lumbar Degenerative Disc Disease | Biotech Hunter | Biotech Hunter